TCR² Therapeutics
Kai Wucherpfennig is a Professor and Chairman of the Department of Cancer Immunology and Virology Director of Center for Cancer Immunotherapy Research, Boston, MA.
This person is not in the org chart
This person is not in any offices
TCR² Therapeutics
TCR² Therapeutics Inc. is a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer.